Processa Pharmaceuticals Share Price (NASDAQ: PCSA)
$0.19
Last updated on
Check the interactive Processa Pharmaceuticals Stock chart to analyse performance
Processa Pharmaceuticals stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$0.18Today's High:$0.20
4.47%
Downside
Day's Volatility :11.2%
Upside
7.05%
- 52 Weeks Low:$0.1552 Weeks High:$1.50
21.05%
Downside
52 Weeks Volatility :90.0%
Upside
87.33%
Processa Pharmaceuticals Stock Returns
Processa Pharmaceuticals Inc Key Stats
Check Processa Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Processa Pharmaceuticals Stock including INR - Dollar returns
The Processa Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Processa Pharmaceuticals investment value today
Current value as on today
₹18,759
Returns
Returns from Processa Pharmaceuticals Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Processa Pharmaceuticals Stock
Global Institutional Holdings in Processa Pharmaceuticals Inc
Name
Holdings %
Alpine Partners VI, LLC
1.64%
Virtu Financial LLC
1.32%
Geode Capital Management, LLC
1.05%
Vanguard Group Inc
0.75%
Sequoia Financial Advisors LLC
0.34%
Tower Research Capital LLC
0.08%
Analyst Recommendation on Processa Pharmaceuticals Stock
Buy
77%Buy
22%Hold
0%Sell
Based on 9 Wall street analysts offering stock ratings for Processa Pharmaceuticals(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Processa Pharmaceuticals Share Price Target
What analysts predicted
Upside of 952.63%
Target:
$2.00
Current:
$0.19
Processa Pharmaceuticals share price target is $2.00, a slight Upside of 952.63% compared to current price of $0.19 as per analysts' prediction.
Processa Pharmaceuticals Stock Insights
Price Movement
In the last 7 days, PCSA stock has moved down by -11.3%PCSA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 155.9%PCSA vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 212.3%
Processa Pharmaceuticals Technicals Summary
Sell
Neutral
Buy
Processa Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Processa Pharmaceuticals Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -8.56% | -60.61% | -86.28% | -99.64% | -99.76% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -0.54 | -2.12 | -1.03 | NA | 0.15 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $10.7M | -99.76% | NA | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Processa Pharmaceuticals Inc
Key Management of Processa Pharmaceuticals Inc
Important FAQs about investing in PCSA Stock from India :
What is Processa Pharmaceuticals share price today?
Processa Pharmaceuticals share price today is $0.19 as on at the close of the market. Processa Pharmaceuticals share today touched a day high of $0.20 and a low of $0.18.
What is the 52 week high and 52 week low for Processa Pharmaceuticals share?
Processa Pharmaceuticals share touched a 52 week high of $1.50 and a 52 week low of $0.15. Processa Pharmaceuticals stock price today i.e. is closed at $0.19, lower by 87.33% versus the 52 week high.
How to invest in Processa Pharmaceuticals Stock (PCSA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Processa Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Processa Pharmaceuticals Shares that will get you 7.8947 shares as per Processa Pharmaceuticals share price of $0.19 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Processa Pharmaceuticals Stock (PCSA) from India?
Indian investors can start investing in Processa Pharmaceuticals (PCSA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Processa Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Processa Pharmaceuticals share’s latest price of $0.19 as on August 30, 2025 at 1:29 am IST, you will get 52.6316 shares of Processa Pharmaceuticals. Learn more about
fractional shares .
What are the returns that Processa Pharmaceuticals has given to Indian investors in the last 5 years?
Processa Pharmaceuticals stock has given -99.76% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%